7PPA
High resolution structure of bone morphogenetic protein receptor type II (BMPRII) extracellular domain in complex with BMP10
7PPA の概要
エントリーDOI | 10.2210/pdb7ppa/pdb |
分子名称 | Bone morphogenetic protein 10, Bone morphogenetic protein receptor type-2, GLYCEROL, ... (4 entities in total) |
機能のキーワード | bmprii bmp10 tgf-beta ligand and receptor signalling complex, cytokine |
由来する生物種 | Homo sapiens (Human) 詳細 |
タンパク質・核酸の鎖数 | 4 |
化学式量合計 | 52377.20 |
構造登録者 | |
主引用文献 | Guo, J.,Liu, B.,Thorikay, M.,Yu, M.,Li, X.,Tong, Z.,Salmon, R.M.,Read, R.J.,Ten Dijke, P.,Morrell, N.W.,Li, W. Crystal structures of BMPRII extracellular domain in binary and ternary receptor complexes with BMP10. Nat Commun, 13:2395-2395, 2022 Cited by PubMed Abstract: Heterozygous mutations in BMPR2 (bone morphogenetic protein (BMP) receptor type II) cause pulmonary arterial hypertension. BMPRII is a receptor for over 15 BMP ligands, but why BMPR2 mutations cause lung-specific pathology is unknown. To elucidate the molecular basis of BMP:BMPRII interactions, we report crystal structures of binary and ternary BMPRII receptor complexes with BMP10, which contain an ensemble of seven different BMP10:BMPRII 1:1 complexes. BMPRII binds BMP10 at the knuckle epitope, with the A-loop and β4 strand making BMPRII-specific interactions. The BMPRII binding surface on BMP10 is dynamic, and the affinity is weaker in the ternary complex than in the binary complex. Hydrophobic core and A-loop interactions are important in BMPRII-mediated signalling. Our data reveal how BMPRII is a low affinity receptor, implying that forming a signalling complex requires high concentrations of BMPRII, hence mutations will impact on tissues with highest BMPR2 expression such as the lung vasculature. PubMed: 35504921DOI: 10.1038/s41467-022-30111-2 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (1.48 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード